skip to main content
Idioma:
Você quis dizer: peter cody j?
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Interventional pharmacoeconomics for immune checkpoint inhibitors through alternative dosing strategies
Interventional pharmacoeconomics for immune checkpoint inhibitors through alternative dosing strategies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Interventional pharmacoeconomics for immune checkpoint inhibitors through alternative dosing strategies

Wesevich, Austin ; Goldstein, Daniel A ; Paydary, Koosha ; Peer, Cody J ; Figg, William D ; Ratain, Mark J

British journal of cancer, 2023-10, Vol.129 (9), p.1389-1396 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases
Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases
Material Type:
Artigo 		Adicionar ao Meu Espaço

Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases

Gril, Brunilde ; Paranjape, Anurag N ; Woditschka, Stephan ; Hua, Emily ; Dolan, Emma L ; Hanson, Jeffrey ; Wu, Xiaolin ; Kloc, Wojciech ; Izycka-Swieszewska, Ewa ; Duchnowska, Renata ; Pęksa, Rafał ; Biernat, Wojciech ; Jassem, Jacek ; Nayyar, Naema ; Brastianos, Priscilla K ; Hall, O Morgan ; Peer, Cody J ; Figg, William D ; Pauly, Gary T ; Robinson, Christina ; Difilippantonio, Simone ; Bialecki, Emilie ; Metellus, Philippe ; Schneider, Joel P ; Steeg, Patricia S

Nature communications, 2018-07, Vol.9 (1), p.2705-18, Article 2705 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors
Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors

Marzi, Laetitia ; Agama, Keli ; Murai, Junko ; Difilippantonio, Simone ; James, Amy ; Peer, Cody J ; Figg, William D ; Beck, Daniel ; Elsayed, Mohamed S A ; Cushman, Mark ; Pommier, Yves

Molecular cancer therapeutics, 2018-08, Vol.17 (8), p.1694-1704 [Periódico revisado por pares]

United States: American Association for Cancer Research Inc

Texto completo disponível

Citações Citado por
4
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease

Curtis, Lauren M. ; Ostojic, Alen ; Venzon, David J. ; Holtzman, Noa G. ; Pirsl, Filip ; Kuzmina, Zoya J. ; Baird, Kristin ; Rose, Jeremy J. ; Cowen, Edward W. ; Mays, Jacqueline W. ; Mitchell, Sandra A. ; Parsons-Wandell, Laura ; Joe, Galen O. ; Comis, Leora E. ; Berger, Ann ; Pusic, Iskra ; Peer, Cody J. ; Figg, William D. ; Cao, Liang ; Gale, Robert Peter ; Hakim, Frances T. ; Pavletic, Steven Z.

Blood, 2021-02, Vol.137 (7), p.896-907 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Efficacy, Tolerability, and Pharmacokinetics of Combined Targeted MEK and Dual mTORC1/2 Inhibition in a Preclinical Model of Mucosal Melanoma
Efficacy, Tolerability, and Pharmacokinetics of Combined Targeted MEK and Dual mTORC1/2 Inhibition in a Preclinical Model of Mucosal Melanoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy, Tolerability, and Pharmacokinetics of Combined Targeted MEK and Dual mTORC1/2 Inhibition in a Preclinical Model of Mucosal Melanoma

Wei, Bih-Rong ; Hoover, Shelley B ; Peer, Cody J ; Dwyer, Jennifer E ; Adissu, Hibret A ; Shankarappa, Priya ; Yang, Howard ; Lee, Maxwell ; Peat, Tyler J ; Figg, William D ; Simpson, R Mark

Molecular cancer therapeutics, 2020-11, Vol.19 (11), p.2308-2318 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
6
Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia
Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia

PEER, Cody J ; SISSUNG, Tristan M ; FEDERSPIEL, Joel ; VENZON, David ; DAHUT, William ; KOHN, Elise ; KUMMAR, Shivaani ; YARCHOAN, Robert ; GIACCONE, Giuseppe ; WIDEMANN, Brigitte ; FIGG, William D ; KIM, Aerang ; JAIN, Lokesh ; WOO, Sukyung ; GARDNER, Erin R ; KIRKLAND, C. Tyler ; TROUTMAN, Sarah M ; ENGLISH, Bevin C ; RICHARDSON, Emily D

Clinical cancer research, 2012-04, Vol.18 (7), p.2099-2107 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
7
Metastasis-Specific Gene Expression in Autochthonous and Allograft Mouse Mammary Tumor Models: Stratification and Identification of Targetable Signatures
Metastasis-Specific Gene Expression in Autochthonous and Allograft Mouse Mammary Tumor Models: Stratification and Identification of Targetable Signatures
Material Type:
Artigo 		Adicionar ao Meu Espaço

Metastasis-Specific Gene Expression in Autochthonous and Allograft Mouse Mammary Tumor Models: Stratification and Identification of Targetable Signatures

Ross, Christina ; Szczepanek, Karol ; Lee, Maxwell ; Yang, Howard ; Peer, Cody J ; Kindrick, Jessica ; Shankarappa, Priya ; Lin, Zhi-Wei ; Sanford, Jack D ; Figg, William D ; Hunter, Kent W

Molecular cancer research, 2020-09, Vol.18 (9), p.1278-1289 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
8
Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironment
Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironment

Zhang, Xianyu ; Yu, Yunkai ; Peer, Cody J. ; Landsman, Rebekah ; Skorupan, Nebojsa ; Cao, Liang ; Alewine, Christine

Translational oncology, 2022-07, Vol.21, p.101440-101440, Article 101440 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
9
Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers
Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers

Skorupan, Nebojsa ; Peer, Cody J ; Zhang, Xianyu ; Choo-Wosoba, Hyoyoung ; Ahmad, Mehwish I ; Lee, Min-Jung ; Rastogi, Shraddha ; Sato, Nahoko ; Yu, Yunkai ; Pegna, Guillaume Joe ; Steinberg, Seth M ; Kalsi, Shelley S ; Cao, Liang ; Figg, William D ; Trepel, Jane B ; Pastan, Ira ; FitzGerald, David ; Alewine, Christine

Frontiers in oncology, 2024, Vol.14, p.1386190-1386190 [Periódico revisado por pares]

Switzerland: Frontiers Media S.A

Texto completo disponível

Citações Citado por
10
Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumors
Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumors

Parkhurst, Ashlyn ; Wang, Sabrina Z ; Findlay, Tyler R ; Malebranche, Kristen J ; Odabas, Arman ; Alt, Jesse ; Maxwell, Micah J ; Kaur, Harpreet ; Peer, Cody J ; Figg, William D ; Warren, Katherine E ; Slusher, Barbara S ; Eberhart, Charles G ; Raabe, Eric H ; Rubens, Jeffrey A

Cell death & disease, 2022-04, Vol.13 (4), p.410-14, Article 410 [Periódico revisado por pares]

England: Springer Nature B.V

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (192)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (194)
  2. Reports  (2)
  3. Imagens  (1)
  4. Anais de Congresso  (1)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.